SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 29, 16:00
2937.25
-23.4 (-0.79%)
VOLUME 82,496
LIVE
NSE
Jul 29, 15:59
2935.35
-24.4 (-0.82%)
VOLUME 689,747
Announcements on Dr Reddys Labs

28th-Jul-2016 08:11Source: BSE

Dr Reddys Labs- Grant of Equity Shares

Dr Reddys Laboratories Ltd has informed BSE that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on July 26,2016, had granted 157,272...

28th-Jul-2016 08:07Source: BSE

Dr Reddys Labs- Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Dr Reddys Laboratories Ltd has informed BSE regarding the details of Voting results at the 32nd Annual General Meeting (AGM) of the Company held on July 27, 2016, under Regulation 44(3) of SEBI (LODR)...

27th-Jul-2016 08:57Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 26, 2016 titled "Dr.Reddy's Q1 FY17 Financial Results".

27th-Jul-2016 08:42Source: BSE

Dr Reddys Labs- Updates on Financial Results for June 30, 2016 (Limited Review)

With reference to the earlier letter dated July 26, 2016, regarding the Unaudited Financial Results for the quarter ended June 30, 2016.

In this regard, Dr Reddys Laboratories Ltd has now infor...

26th-Jul-2016 14:51Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended June 30, 2016.

26th-Jul-2016 14:43Source: BSE

Dr Reddys Labs- Announces Q1 (Standalone & Consolidated) results, Limited Review Report (Standalone & Consolidated) & Results Press Release for the Quarter ended June 30, 2016

Dr Reddys Laboratories Ltd has announced the following results for the quarter ended June 30, 2016:

The Unaudited Standalone results for the Quarter ended June 30, 2016

The Company has p...

21st-Jul-2016 16:03Source: BSE

Dr Reddys Labs- Shareholding for the Period Ended June 30, 2016

Dr Reddys Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly

18th-Jul-2016 11:32Source: BSE

Dr Reddys Labs- Dr. Reddy's Laboratories announces the launch of Omeprazole and Sodium bicarbonate capsules in the U.S. Market

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated July 18, 2016 titled "Dr. Reddy''s Laboratories announces the launch of Omeprazole and Sodium bicarbonate capsules in the U....

14th-Jul-2016 10:16Source: BSE

Dr Reddys Labs- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

Dr Reddys Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (L...

13th-Jul-2016 08:21Source: BSE

Dr Reddys Labs- Press Release

Dr Reddys Laboratories Ltd has submitted to BSE a copy of Press Release dated July 12, 2016 titled ''''Dr. Reddy''s to release Q1 FY17 results on July 26, 2016, Earnings call slated for July 26, 6.30 ...

1 2 3 4 5 Next >>
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.